1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with curcumin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Qiu, Y; Sun, H; Yu, T | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and curcumin
Article | Year |
---|---|
1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ceramides; Curcumin; Drug Synergism; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Melanoma; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2012 |